慢性危重症患者代理决策者的创伤后应激障碍症状簇
本文为一项沟通干预临床试验数据的二次分析,对象为3家三级中心内科ICU和1家社区医院中慢性危重症(机械通气≥7天且预计72小时内不会死亡或脱机)患者及其代理决策者。在患者慢性危重症起病90天后用事件影响量表修订版(IES-R)测量代理决策者PTSD症状,侵入症状最重(均分10.3,95%CI 9.3-11.2),回避次之(8.0,95%CI 7.2-8.8),高唤醒最低(5.1,95%CI 4.5-5.7)。多变量线性回归显示患者死亡者代理决策者侵入症状(β 5.52,p<0.0001)与回避症状(β 3.29,p=0.001)更高,高唤醒与患者死亡无关。结果可能有助于制定针对该人群的个体化治疗策略以减轻PTSD症状。
要点
- 慢性危重症患者代理决策者在患者起病90天后PTSD症状以侵入性症状最重,均分10.3(95%CI 9.3-11.2)。
- 回避症状均分8.0(95%CI 7.2-8.8),高唤醒症状最低,均分5.1(95%CI 4.5-5.7)。
- 患者死亡者代理决策者侵入症状β 5.52(p<0.0001)、回避症状β 3.29(p=0.001),均高于患者存活者。
- 患者死亡与高唤醒症状无关。
- 作者认为这些结果可能有助于制定个体化治疗策略以减轻该人群PTSD症状。
适用人群与场景
- 慢性危重症患者(机械通气≥7天,且预计随后72小时内不会死亡或脱机)及其代理决策者。
- 原试验在3家三级医疗中心的内科ICU和1家社区医院进行。
诊断标准与关键阈值
- 慢性危重症定义:机械通气≥7天且预计随后72小时内不会死亡或不会脱机。
- PTSD症状采用事件影响量表修订版(IES-R)评估:总分范围0-88分,分数越高症状越重;侵入与回避分量表各0-32分,高唤醒分量表0-24分。
研究设计与关键结果
- 研究类型:一项沟通干预临床试验数据的二次分析;原试验在3家三级医疗中心内科ICU和1家社区医院进行;干预:无。
- 在患者慢性危重症起病90天后测量代理决策者PTSD症状:侵入症状最重(均分10.3;95%CI 9.3-11.2),回避次之(均分8.0;95%CI 7.2-8.8),高唤醒最低(均分5.1;95%CI 4.5-5.7)。
- 多变量线性回归模型显示,调整基线焦虑和抑郁症状后,患者死亡者代理决策者侵入症状(β 5.52;p<0.0001)和回避症状(β 3.29;p=0.001)高于患者存活者。
- 患者死亡与高唤醒症状无关。
证据类型、等级与局限
- 证据类型:临床试验数据的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些结果可能有助于制定个体化治疗策略以减轻慢性危重症患者代理决策者的PTSD症状。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Symptoms of posttraumatic stress disorder (PTSD) are common among surrogate decision makers of patients with chronic critical illness (CCI). PTSD symptoms can be categorized into clusters including intrusion, avoidance, and hyperarousal, each of which has been associated with distinct outcomes and treatment responses. Our objective was to determine which symptom cluster was predominant among surrogates of patients with CCI.
DESIGN: Secondary analysis of data from a clinical trial of a communication intervention.
SETTING: The original trial was conducted in medical intensive care units at three tertiary-care centers and one community hospital.
PATIENTS: Patients with CCI (≥7 d of mechanical ventilation and not expected to die or to be weaned from the ventilator in the subsequent 72 hr) and their surrogates.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Surrogate PTSD symptoms were measured 90 days after onset of patient CCI using the Impact of Events Scale-Revised (IES-R). The IES-R includes a total score (range, 0-88, higher scores indicate severe symptoms) as well as three subscales that assess intrusion, avoidance, and hyperarousal (range of intrusion and avoidance scores 0-32 and range of hyperarousal score 0-24). Intrusion symptoms were most severe (mean score, 10.3; 95% CI, 9.3-11.2), followed by avoidance (mean score, 8.0; 95% CI, 7.2-8.8). Hyperarousal symptoms were lowest (mean score, 5.1; 95% CI, 4.5-5.7). In a multivariable linear regression model, we found that surrogates of patients who died had higher odds of intrusion (β, 5.52; p < 0.0001) and avoidance (β, 3.29; p = 0.001) symptoms than surrogates of patients who lived, even after adjusting for baseline symptoms of anxiety and depression. Patient death was not associated with hyperarousal symptoms.
CONCLUSIONS: Intrusive thoughts are the most severe PTSD symptom in surrogates of patients experiencing CCI, with intensified symptoms among surrogates of patients who died. These results have the potential to inform tailored treatment strategies to reduce PTSD symptoms in this population.
参考来源
- Wendlandt B, Ceppe A, Gaynes BN, et al. Posttraumatic Stress Disorder Symptom Clusters in Surrogate Decision Makers of Patients Experiencing Chronic Critical Illness. Crit Care Explor. 2022. PMID: 35261980. doi:10.1097/CCE.0000000000000647
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。